Citigroup Inc Applied Molecular Transport Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.35 - $1.26 $8 - $30	24 Added 3.79%	658 $0
Q3 2022 Nov 10, 2022	SELL	$1.12 - $3.12 $268 - $748	-240 Reduced 27.46%	634 $1,000
Q2 2022 Aug 10, 2022	SELL	$2.76 - $7.65 $3,386 - $9,386	-1,227 Reduced 58.4%	874 $3,000
Q1 2022 May 12, 2022	SELL	$5.63 - $13.88 $40,530 - $99,922	-7,199 Reduced 77.41%	2,101 $16,000
Q4 2021 Feb 10, 2022	SELL	$13.23 - $26.05 $329,427 - $648,645	-24,900 Reduced 72.81%	9,300 $130,000
Q3 2021 Nov 10, 2021	BUY	$25.87 - $46.61 $884,754 - $1.59 Million	34,200 New	34,200 $885,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.